3201 Hospital

Running trials

• Recruiting

  Upadacitinib Versus Infliximab as Second-Line Treatment for Acute Severe Ulcerative Colitis（UPRISE）

  NCT07550673· Phase 4· Source

• Recruiting

  Comparative Effectiveness of Upadacitinib vs Corticosteroids as First-Line Therapy for Acute Severe Ulcerative Colitis（UPFRONT）

  NCT07546097· Phase 4· Source

• Recruiting

  TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer

  NCT07047365· Phase 3· Source

• Recruiting

  Antithrombotic Drug Use in Patients With Ischemic Stroke and Microbleeds

  NCT05032053· Source

• Active, not recruiting

  A Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line Treatment in Subjects With RAS/BRAF Wild Metastatic Colorectal Cancer

  NCT04854668· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Ulcerative colitis2 recruiting
• Metastatic breast cancer1 recruiting
• Stroke1 recruiting

Researchers

No researcher is linked here yet.